Your browser doesn't support javascript.
loading
Differential histopathologic parameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials.
Cremolini, Chiara; Milione, Massimo; Marmorino, Federica; Morano, Federica; Zucchelli, Gemma; Mennitto, Alessia; Prisciandaro, Michele; Lonardi, Sara; Pellegrinelli, Alessio; Rossini, Daniele; Bergamo, Francesca; Aprile, Giuseppe; Urbani, Lucio; Morelli, Luca; Schirripa, Marta; Cardellino, Giovanni Gerardo; Fassan, Matteo; Fontanini, Gabriella; de Braud, Filippo; Mazzaferro, Vincenzo; Falcone, Alfredo; Pietrantonio, Filippo.
Afiliação
  • Cremolini C; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, 56126, Italy.
  • Milione M; Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori - Via Venezian, 20100, Milano, Italy. massimo.milione@istitutotumouri.mi.it.
  • Marmorino F; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, 56126, Italy.
  • Morano F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori - Via Venezian, 1, 20100, Milano, Italy.
  • Zucchelli G; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, 56126, Italy.
  • Mennitto A; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori - Via Venezian, 1, 20100, Milano, Italy.
  • Prisciandaro M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori - Via Venezian, 1, 20100, Milano, Italy.
  • Lonardi S; Unit of Medical Oncology 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua, 35128, Padova, Italy.
  • Pellegrinelli A; Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori - Via Venezian, 20100, Milano, Italy.
  • Rossini D; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, 56126, Italy.
  • Bergamo F; Unit of Medical Oncology 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua, 35128, Padova, Italy.
  • Aprile G; Department of Oncology, University & General Hospital, Udine - Pz.le S. Maria della Misericordia 15, 33100, Udine, Italy.
  • Urbani L; General Hospital, ULSS8 Berica - East District, 36100, Vicenza, Italy.
  • Morelli L; General Surgery Unit, Azienda Ospedaliero-Universitaria Pisana, Ospedale Nuovo Santa Chiara, Cisanello, 56124, Pisa, Italy.
  • Schirripa M; 1st General Surgery Unit, Azienda Ospedaliero-Universitaria Pisana, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56124, Pisa, Italy.
  • Cardellino GG; Unit of Medical Oncology 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua, 35128, Padova, Italy.
  • Fassan M; Department of Oncology, University & General Hospital, Udine - Pz.le S. Maria della Misericordia 15, 33100, Udine, Italy.
  • Fontanini G; Surgical Pathology Unit, Department of Medicine University of Padua, Padua, via Giustiniani 2, 56126, Padova, Italy.
  • de Braud F; Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa - Via Roma, 67 56126, Pisa, Italy.
  • Mazzaferro V; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori - Via Venezian, 1, 20100, Milano, Italy.
  • Falcone A; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Pietrantonio F; General Surgery and Liver Surgery, Transplantation and Gastroenterology, University of Milan, IRCCS Istituto Nazionale Tumori Fondazione, 20100, Milan, Italy.
Br J Cancer ; 118(7): 955-965, 2018 04.
Article em En | MEDLINE | ID: mdl-29531324
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Bevacizumab / Cetuximab / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Bevacizumab / Cetuximab / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália